Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 3Colonic Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Polyps 1Patient Satisfaction 1Neurofibromatoses 1Malignant Neoplasms of Male Genital Organs 1Lung Neoplasms 1Hydrocephalus 1Headache 1Epilepsy 1Diverticulosis, Colonic 1Agnosia 1Abdominal Neoplasms 1

Interventions

Leucovorin 38Fluorouracil 36Oxaliplatin 34Bevacizumab 34Irinotecan 32Cetuximab 23Capecitabine 18Panitumumab 14IFL protocol 7Folfox protocol 6Celecoxib 6Radiotherapy 5Nivolumab 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gene Expression Profiling 5regorafenib 4pembrolizumab 4dehydroftorafur 4Ramucirumab 4Fluorodeoxyglucose F18 4Floxuridine 4aflibercept 3Surgical Procedures, Operative 3Sorafenib 3Radiosurgery 3Ipilimumab 3Gemcitabine 3Fentanyl 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Colonic Neoplasms × Propofol × Clear all
NCT01488045 2023-05-23

Compare Propofol to Fentanyl and Midazolam for Colonoscopy

Trinity Health Michigan

Phase NA Completed
289 enrolled 10 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Diverticulosis, Colonic

NCT02937506 2017-12-26

Patient Satisfaction With Propofol for Out Patient Colonoscopy

Mount Carmel Health System

Phase 4 Completed
600 enrolled 5 charts
Gastrointestinal

Colonic Neoplasms, Polyps, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡